Epidermal Growth Factor Receptor (EGFR) Inhibitors Market to grow by USD 6.75 billion from 2024 to 2028, North America to account for 40% of market growth- Technavio

Source :: PR Newswire. October 30, 2023
Publication Year :: 2023
Abstract: NEW YORK, Oct. 30, 2023 /PRNewswire/ -- The https://www.technavio.com/report/epidermal-growth-factor-receptor-egfr-inhibitors-market-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=T2023_sv_wk44_2023_021_rep&utm_content=IRTNTR72701 size is expected to grow byUSD 8.39 billion from 2023 to 2028. In addition, the momentum of the market will progress [...]

Subjects :: Takeda Pharmaceutical Company Ltd. -- Forecasts and trends
Amgen Inc. -- Forecasts and trends
Johnson & Johnson -- Forecasts and trends
Bristol-Myers Squibb Co. -- Forecasts and trends
Pfizer Inc. -- Forecasts and trends
Boehringer Ingelheim GmbH -- Forecasts and trends
Novartis AG -- Forecasts and trends
Otsuka Holdings Company Ltd. -- Forecasts and trends
AstraZeneca PLC -- Forecasts and trends
F. Hoffmann-La Roche Ltd. -- Forecasts and trends
Eli Lilly and Co. -- Forecasts and trends
Biotechnology industry -- Forecasts and trends
Health products industry -- Forecasts and trends
Panitumumab -- Forecasts and trends
Epidermal growth factor -- Forecasts and trends
Pharmaceutical industry -- Forecasts and trends
Market trend/market analysis
Business
News, opinion and commentary

Tools